Researchers on Friday hailed a new procedure that could allow type 2 diabetics to control their blood sugar levels without having to take insulin, early findings that offer millions of people hope ...
ReCET technology, manufactured by Endogenex, uses a specialized catheter that ablates the duodenal mucosa with electroporation, enhancing sensitivity to endogenous insulin. In the first-in-human study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback